Combination therapy shows improvement for breast cancer patients

	Tweet

Giving radiation therapy and chemotherapy at the same time after a lumpectomy helps keep breast cancer from returning locally, according to a study published in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.

Breast cancer widely affects women in the United States, with more than 213,000 women estimated to be diagnosed in 2006. For early-stage breast cancer, the standard treatment is a lumpectomy (surgical removal of the tumor) followed by radiation therapy to the entire breast. Doctors usually recommend chemotherapy in addition for women with invasive disease. When to give the chemotherapy - whether after surgery, but before radiation or after surgery and radiation - has been widely debated among researchers.

Cancer researchers at Yale New Haven Hospital in New Haven, Conn., and the Cancer Institute of New Jersey, New Brunswick, N.J., wanted to try to answer the question as to the proper sequencing of chemotherapy. Doctors recorded data from more than 2,000 patients over the course of nearly 25 years. Of those women, 535 patients were treated with the different sequencing of chemotherapy and radiation therapy. Patients were then grouped by how they received the treatment, 276 women received chemotherapy before radiation therapy, 106 women received radiation therapy before chemotherapy, 109 women received concurrent chemotherapy and radiation and 44 women received the “sandwich” technique of alternating chemotherapy with radiation therapy and then repeating chemotherapy.

The outcome for the women in the study was successful across the group, with 10-year overall survival at 78 percent. Doctors found that there was no significant difference in the way these combinations affected the general patient outcome, but there was a difference in where tumors could relapse. Of the 109 patients who received chemotherapy and radiation therapy at the same time, only 8 percent relapsed locally (in the conservatively treated breast) over 10 years. Of the women who received radiation therapy before chemotherapy, 13 percent had a local relapse while 22 percent of the women who had chemotherapy before radiation had a local relapse.

“It is important for doctors to test and retest combinations of treatments and how we deliver them to our patients. In this retrospective analysis, by concurrently administering chemotherapy and radiation therapy, there appears to be a benefit to selected patients in terms of local control of the breast cancer. The challenge over the next few years is to identify those patients who would best benefit from this strategy. This can best be accomplished by prospective clinical trials,” said Bruce G. Haffty, M.D., lead author of the study and a radiation oncologist at Robert Johnson Wood Medical School-UMDNJ and the Cancer Institute of New Jersey, in New Brunswick, N.J.

American Society for Therapeutic Radiology and Oncology

RELATED STORIES:
8 Natural Ways to Prevent Breast Cancer   Annual screening with breast ultrasound or MRI could benefit some women   Lack of Care For Older Breast Cancer Patients   Tumor-free breast tissue can have precancerous changes   Heart disease beats breast cancer as the biggest killer   Painkiller can boost breast cancer survival rates   Many Women Who Had Childhood Cancer Do Not Undergo Breast Cancer Screening   Whites take supplemental breast cancer therapy more often than blacks   Canadian breast cancer screening guidelines would cost thousands of lives   Genetic testing helped breast cancer survivor   FISH Technology Preferred for Choosing HER-2-Positive Breast Cancer Treatments   IOM Report On Breast Cancer And The Environment   Younger breast cancer patients have more adverse quality-of-life issues   New possibilities for breast cancer treatment on the horizon   Genetic Variants May Affect the Risk of Breast Cancer in Women with BRCA2 Mutations   PET Techniques Provide More Accurate Diagnosis, Prognosis in Challenging Breast Cancer Cases   Breast cancer incidence is lower for Latinas   New leaflet offers breast cancer help   Study aims to find which breast cancer patients need chemotherapy   A genetic ‘gang of 4’ drives spread of breast cancer   Women with BRCA Mutation, Or High Degree of Worry, Most Likely to Undergo Prophylactic Mastectomy   Combo therapy slows breast cancer progression

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]